Background and purpose New‐onset refractory status epilepticus (NORSE) is a clinical
presentation, neither a specific diagnosis nor a clinical entity. It refers to a patient without …

Objective This study was undertaken to develop consensus‐based recommendations for the
management of adult and pediatric patients with new onset refractory status epilepticus …

New-onset refractory status epilepticus (NORSE) is “a clinical presentation, not a specific
diagnosis, in a patient without active epilepsy or other preexisting relevant neurological …

Importance Super-refractory status epilepticus (SRSE) is defined as status epilepticus (SE)
that continues or recurs 24 hours or more after the onset of anesthetic therapy or recurs on …

Objective This study was undertaken to characterize the blood–brain barrier (BBB)
dysfunction in patients with new onset refractory status epilepticus (NORSE) using dynamic …

The use of ketogenic diet therapies (KDT) in adults has expanded in the last two decades
and has been accompanied by a surge of new retrospective as well as prospective studies …

Little is known of the etiology, course, and treatment of new-onset refractory status
epilepticus (NORSE) in children. Here we identified etiologies, electroencephalography …

Objective To determine whether a clinically based score predicts cryptogenic new-onset
refractory status epilepticus (C-NORSE) at the early stage of status epilepticus (SE) with …

New onset refractory status epilepticus (NORSE), including its subtype with a preceding
febrile illness known as febrile infection‐related epilepsy syndrome (FIRES), is one of the …

Refractory status epilepticus (RSE) is a life-threatening emergency with high mortality and
poor functional outcomes in survivors. Treatment is typically limited to intravenous anesthetic …